LinkedIn co-founder Reid Hoffman announced the launch of Manas AI company, which aims to transform the drug industry. Hoffman said that his new full stack company would help in shifting the drug discovery from a decade-long process to the one that would take a few years. He emphasised that Manas AI could help bring life-saving treatments to patients faster than ever. The AI drug discovery company has already raised USD 24.6 million in seed funding from Reid Hoffman, Greylock and General Catalyst. OpenAI CEO Sam Altman Reacts to Rise of Chinese AI Chatbot, Says DeepSeek R-1 Is ‘Impressive’ but We Will Obviously Deliver Much Better Models.

LinkedIn Co-Founder Reid Hoffman Launched 'Manas AI' Drug Discovery Company 

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)